Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 1, 2008, Pages 75-83

  Otero Fernández, Rafael ^a   Gómez Outes, Antonio ^b   Martínez González, Javier ^b   Rocha, Eduardo ^c   Fontcuberta, Jordi ^d  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Bemiparin; Low molecular weight heparin; Orthopedic surgery; Prophylaxis; Venous thromboembolism

Indexed keywords

BADYKET; BEMIPARIN; IVOR; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; ZIBOR;

ADULT; ARTICLE; BLEEDING; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; DEATH; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HIP FRACTURE; HUMAN; IMMOBILIZATION; KNEE ARTHROPLASTY; KNEE ARTHROSCOPY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OBSERVATIONAL STUDY; ORTHOPEDICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SPINE SURGERY; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; CHEMOPREVENTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMOBILIZATION; INCIDENCE; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 37549060400     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607303962     Document Type: Article

References (23)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2004 ; 126: 338S-400S.
2. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlebologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006 ; 25: 101-161.
3. Planes A. Review on bemiparin sodium-a new second generation low-molecular-weight heparin-and its applications in venous thromboembolism. Expert Opin Pharmacother. 2003 ; 4: 1551-1561.
4. Kakkar VV, Howes J., Sharma V., et al. A comparative, double-blind, randomized trial of a new second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment Group. Thromb Haemost. 2000 ; 83: 523-529.
5. Navarro-Quilis A., Castellet E., Rocha E.,, et al. Bemiparin Study Group in Knee Arthroplasty. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial. J Thromb Haemost. 2003 ; 1: 425-432.
6. Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest. 2003 ; 124 (suppl 6). 386S - 392S.
7. Lassen MR, Borris LC, Nakov RL Use of the low-molecular-weight heparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med. 2002 ; 347: 726-730.
8. Zagrodnick J., Kaufner HK Ambulatory thromboembolism prevention in traumatology using self-injection of heparin [in German]. Unfallchirurg. 1990 ; 93: 331-333.
9. Jorgensen PS, Warming T., Hansen K., et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res. 2002 ; 105: 477-480.
10. Kock HJ, Schmit-Neuerburg KP, Hanke J., et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995 ; 346: 459-461.
11. Kujath P., Spannagel U., Habscheid W. Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis. 1993 ; 23 (suppl 1). 20-26.
12. Bergqvist D., Lowe G. Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts. Arch Intern Med. 2002 ; 162: 2173-2176.
13. Hoppener MR, Ettema HB, Henny CP, et al. Symptomatic deep vein thrombosis and immobilization after day-care arthroscopy of the knee. J Thromb Haemost. 2005 ; 3: 185-187.
14. Allum R. Complications of arthroscopy of the knee. J Bone Joint Surg Br. 2002 ; 84: 937-945.
15. Turner JA, Ersek M., Herron L., et al. Patient outcomes after lumbar spinal fusions. JAMA. 1992 ; 268: 907-911.
16. Eikelboom JW, Quinlan DJ, Douketis JD Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001 ; 358: 9-15.
17. Rosencher N., Vielpeau C., Emmerich J., et al. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost. 2005 ; 3: 2006-2014.
18. Dahl OE, Caprini JA, Colwell CW Jr, et al. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost. 2005 ; 93: 860-866.
19. Kucher N., Leizorovicz A., Vaitkus PT, et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients. A subgroup analysis of the PREVENT trial. Arch Intern Med. 2005 ; 165: 341-345.
20. Planes A. An equivalence study of two low-molecular-weight heparins in the prevention and treatment of deep-vein thrombosis after total hip replacement. Semin Thromb Hemost. 2000 ; 26 (suppl 1). 57-60.
21. Planes A., Vochelle N., Fagola M., et al. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group. Blood Coagul Fibrinolysis. 1998 ; 9: 499-505.
22. Honorato J., Gomez-Outes A., Navarro-Quilis A., Martinez-Gonzalez J., Rocha E., Planes A. Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery. Pharmacoeconomics. 2004 ; 22: 885-894.
23. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996 ; 312: 1215-1218.